Clinical Trials
41
Active:16
Completed:16
Trial Phases
4 Phases
Phase 1:10
Phase 2:12
Phase 3:7
+1 more phases
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)β’ Click on a phase to view related trials
Phase 2
12 (40.0%)Phase 1
10 (33.3%)Phase 3
7 (23.3%)Not Applicable
1 (3.3%)An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery
Phase 2
Completed
- Conditions
- Hypoglycemia
- Interventions
- Drug: XOMA 358 single dose level ADrug: XOMA 358 multiple dose level 1Drug: XOMA 358 single dose level BDrug: XOMA 358 single dose level C
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 20
- Registration Number
- NCT02772718
A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
Phase 2
Completed
- Conditions
- Congenital Hyperinsulinism
- Interventions
- Drug: Cohort 1Drug: Cohort 2Drug: Cohort 3Drug: Cohort 4
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 10
- Registration Number
- NCT02604485
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Phase 3
Terminated
- Conditions
- Pyoderma Gangrenosum
- Interventions
- First Posted Date
- 2014-12-29
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 9
- Registration Number
- NCT02326740
A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
- First Posted Date
- 2014-12-17
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 15
- Registration Number
- NCT02318914
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Phase 3
Terminated
- Conditions
- Pyoderma Gangrenosum
- Interventions
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 16
- Registration Number
- NCT02315417
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found